
    
      This study was double-blind with regards to the Concept1, where placebo for the
      lactose-blended indacaterol was available. However, with regards to the Simoon, neither the
      subject nor the investigator was blinded due to lack of a placebo to the PulmoSphere
      formulation. Hence, the overall designation of the study was partially-blind.
    
  